Back to discover
Drug
Sphingosine
Research stageEmerging research
3
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
How do sphingosine-1-phosphate affect immune cells to resolve inflammation?
Research2024-02-28Frontiers in immunology
Research2023-09-05The Journal of neuroscience : the official journal of the Society for Neuroscience
Research2023-08-10International journal of molecular sciences
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Sphingosine
RxNorm CUI
2710655
ChEMBL ID
CHEMBL67166
UNII
NGZ37HRE42
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Publications over time
20232024
Most influential
Recent papers
Major research themes5
Alzheimer Disease1Immune System1Inflammation1Mental Disorders1Sphingosine1
Journals, researchers & institutions
Top journals
- Frontiers in immunology1
- International journal of molecular sciences1
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
Leading researchers
- Berg AJ1
- Cai Y1
- Caso JR1
- Cheng J1
- Cui T1
- García-Bueno B1
- Leza JC1
- Liu X1
Leading institutions
free-text, unnormalised
- Clinical College1
- First Affiliated Hospital1
- Georgetown University1
- Georgetown University Medical Center1
- Hospital General Universitario Gregorio Marañón1
- Instituto de Investigación Hospital 12 de Octubre (i+12)1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Sphingosine in the shared literature.
1 shared disease1 shared paper
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature